May 16, 2016 β Women younger than 55 years of age who undergo percutaneous coronary intervention (PCI) for acute ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 16, 2016 β A study on the impact of using different anticoagulation medications on men and women who have undergone ...
May 9, 2016 β A new study shows the use of novel anticoagulants to treat atrial fibrillation (AF) on an βas needed basis ...
May 9, 2016 β A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive ...
May 6, 2016 β Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if ...
May 6, 2016Β βΒ The largest risk-directed study by a national hospital system demonstrates a 40 percent decline in ...
April 20, 2016 β Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with ...
April 19, 2016 β In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction ...
April 19, 2016 β Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients ...
April 8, 2016 β New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...
April 1, 2016 β AstraZeneca confirmed that the American College of Cardiology (ACC) and American Heart Association (AHA) ...
March 21, 2016 β The use of novel oral anticoagulants (NOACs) will see a substantial rise after an initially sluggish ...
March 17, 2016 β Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being ...
February 22, 2016 β A new study conducted at Columbia University Medical Center (CUMC) has revealed some of the ...
February 9, 2016 β Cigna has entered into an outcomes-based contract with the pharmaceutical company Novartis for the ...